Provided by Tiger Trade Technology Pte. Ltd.

NGM Biopharmaceuticals Inc

1.54
0.0000
Volume:- -
Turnover:3.70M
Market Cap:128.53M
PE:-0.89
High:1.54
Open:1.54
Low:1.54
Close:1.54
52wk High:4.69
52wk Low:0.6002
Shares:83.46M
Float Shares:28.89M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7258
EPS(LYR):-1.7258
ROE:-69.76%
ROA:-38.46%
PB:0.86
PE(LYR):-0.89

Loading ...

Apr 05, 2024

Delisting

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Apr 05, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Apr 05, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Apr 05, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Apr 05, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Apr 05, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Apr 05, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Apr 05, 2024

Major Issues Report

Form 8-K - Current report
Apr 05, 2024

Privatisation

Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
Apr 05, 2024

Privatisation

Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
Apr 04, 2024

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Mar 23, 2024

Correspondence

Form CORRESP - Correspondence
Mar 22, 2024

Privatisation

Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
Mar 22, 2024

Privatisation

Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
Mar 11, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 11, 2024

Major Issues Report

Form 8-K - Current report
Mar 08, 2024

Privatisation

Form SC 13E3 - Going private transaction by certain issuers
Mar 08, 2024

Privatisation

Form SC TO-T - Tender offer statement by Third Party
Feb 26, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 26, 2024

Major Issues Report

Form 8-K - Current report